A 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine CEP of the European Pharmacopoeia monograph is often referred to as a 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine Certificate of Suitability (COS). The purpose of a 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine to their clients by showing that a 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine CEP has been issued for it. The manufacturer submits a 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine CEP (COS) as part of the market authorization procedure, and it takes on the role of a 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine CEP holder for the record. Additionally, the data presented in the 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine DMF.
A 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 3TC, Zeffix, Heptovir, Epivir, Epivir-HBV, Lamivudine suppliers with CEP (COS) on PharmaCompass.